Oladapo Yeku

35PUBLICATIONS
139CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 16, 2026
IMMU-NO versus yes: Applicability of immune checkpoint inhibitors in gynecologic cancers.

|Jun 17, 2026
Antibody-drug conjugates in gynaecological cancers: opportunities and challenges.

|May 11, 2026
First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma.

|Jan 28, 2026
Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer Therapy.

Adam P Jones, Yanxia Zhao, Bo R Rueda

|Dec 18, 2025
Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers.

Mengyao Xu, Syem K Barakzai, Raj Kumar

|Apr 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.

Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee

Pageof 6

Frequent Collaborators

4 joint publications

Joyce F Liu

4 joint publications

Bo R Rueda

3 joint publications

Kathleen N Moore

3 joint publications

Cheng Wang